NDI Guidance Protects Public Health And Allows Innovation – FDA's Fabricant
This article was originally published in The Tan Sheet
Executive Summary
Present and former top FDA officials with oversight of dietary supplements defend the draft guidance on new dietary ingredient notifications, saying the document serves important public health priorities and will not be onerous to industry.
You may also be interested in...
Probiotics Industry Says FDA Regulatory Bar Is Set Too High
Research on probiotics’ health benefits rapidly grows, but turning studies into label claims lags due to differences between industry, NIH and FDA about standards for claims substantiation. Attendees at a U.S. Pharmacopeia conference outline the challenges to finding common ground
Probiotics Industry Says FDA Regulatory Bar Is Set Too High
Research on probiotics’ health benefits rapidly grows, but turning studies into label claims lags due to differences between industry, NIH and FDA about standards for claims substantiation. Attendees at a U.S. Pharmacopeia conference outline the challenges to finding common ground